logo

FDA Calendar

Share
Company Name ADC Therapeutics
Drug Name Loncastuximab Tesirine (BLA)
Event Name FDA decision on Loncastuximab Tesirine for the treatment of relapsed or refractory diffuse large B-cell lymphoma
Event Date 05/21/2021
Outcome Date
Outcome
Drug Status Priority review
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar